Grant to Advance Metastatic Breast Cancer Research
Danny Welch, PhD, researcher and associate director for Education at The University of Kansas Cancer Center, has been awarded a $100,000 grant from METAvivor.
Cancer Center Members Named to National Breast Cancer Clinical Trials Task Force
Jamie Wagner, DO, FACOS, FACS, division chief, breast surgical oncology, and Shane Stecklein, MD, PhD, radiation oncologist, have been appointed to the Breast Oncology Local Disease (BOLD) Task Force of the National Cancer Institute (NCI) Breast Cancer Steering Committee (BCSC).
Tobacco Treatment Training Program Earns Elite Accreditation
The University of Kansas Tobacco Treatment Specialist training program has been accredited by the Council for Tobacco Treatment Training Programs, joining just 23 other such accredited programs in the world.
Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer
OVERLAND PARK, KAN. – The Women’s Cancer Center at The University of Kansas Cancer Center now offers intraoperative radiation therapy, or IORT, for early-stage breast cancer patients who are treated with lumpectomy. We are the first and only cancer c...
Study Identifies New Therapy Option for Metastatic Breast Cancer
A targeted therapy approved for the treatment of metastatic triple-negative breast cancer may also be effective in the treatment of hormone receptor-positive, HER2-negative breast cancer that has metastasized. Priyanka Sharma, MD, breast medical onco...
Cancer Center Launches Clinical Trial Finder App
A new mobile application developed by The University of Kansas Cancer Center will make it easier for physicians to find clinical trial opportunities for their patients.
Cancer Center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting
Researchers from The University of Kansas Cancer Center are involved in the presentation of nearly 50 research studies at the 62nd American Society of Hematology (ASH) Annual Meeting, to be held virtually Dec. 5-8 because of the COVID-19 pandemic.
Are E-cigarettes Safer Than Cigarettes? Study Sheds Light on the Issue
Scientists and medical professionals have long debated whether e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
Sharing Data for Childhood Cancers
Grant will accelerate precision medicine for pediatric cancer care.
2020 Director’s Award, Pilot and Travel Award Recipients Announced
Recognizing cancer center members and supporters.
Beat AML Clinical Trial: A Paradigm Shift in Treatment
Patients participating in The Leukemia & Lymphoma Society’s (LLS) precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published in the prestigious Nature Medicine journal.
Dense Breast Tissue Care Program Launched
KANSAS CITY, KAN. – The University of Kansas Health System has launched a specialized dense breast care program coinciding with breast cancer awareness month in October. The program helps women who have dense breast tissue understand their risk for...
Grant aims to bring basic scientists and community stakeholders together
New grant will support efforts to create more patient-centered research.
CATCH-UP grant provides more clinical trials to rural, underserved cancer patients
A one-year, $500,000 grant from the National Cancer Institute (NCI) will bring more clinical trial opportunities to cancer patients living in Kansas.